Riskpilot← Back to searchSign inGet full accessCHR. OLESEN PHARMACEUTICALS A/S
A/SActiveCVR 32090168Jægersborg Alle 164Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20092 employees
Revenue 2025
DKK 1,2M
+32% vs 2024
EBITDA margin
48.0%
+54% vs 2024
Equity ratio
15.4%
Financial strength
Net profit 2025
DKK 237K
+237% vs 2024
| Revenue | DKK 1,2M | +32% |
| EBITDA | DKK 581K | +54% |
| Net profit | DKK 237K | +237% |
| Total assets | DKK 11,4M | +5% |
| Equity | DKK 1,7M | +9% |
| Employees | 2 | — |
Legal name
CHR. OLESEN PHARMACEUTICALS A/S
CVR number
32090168
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. marts 2009
Share capital
DKK 588.300
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen, et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed ved handel og distribution af aktive farmaceutiske stoffer til human brug.
Address
Jægersborg Alle 164
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 740 | 1.215 | 1.383 | 916 | 1.211 |
| Staff expenses | -294 | -475 | -531 | -538 | -630 |
| EBITDA | 446 | 740 | 851 | 377 | 581 |
| Depreciation & amort. | -40 | -0 | -0 | -0 | -0 |
| EBIT | 406 | 740 | 851 | 377 | 581 |
| Net financials | -84 | -143 | -310 | -274 | -275 |
| Profit before tax | 322 | 597 | 542 | 104 | 306 |
| Tax | 71 | 132 | 121 | 33 | 68 |
| Net profit | 251 | 465 | 421 | 71 | 237 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 12.958 | 14.986 | 14.065 | 10.836 | 11.360 |
| Equity | 850 | 1.316 | 1.737 | 1.607 | 1.745 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.108 | 13.670 | 12.328 | 9.229 | 9.615 |
| Total debt | 12.108 | 13.670 | 12.328 | 9.229 | 9.615 |
EBITDA margin
48.0%
This company
15.8%
Market median
+204% vs market
20212025
Equity ratio
15.4%
This company
38.2%
Market median
-60% vs market
20212025
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20212025
Net profit margin
19.6%
This company
8.1%
Market median
+142% vs market
20212025
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20212025
Debt / equity
5.51×
This company
0.62×
Market median
-789% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MC Management | Management | 2026 |
PC Management | Management | 2023 |
CD Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (2) | ||
SA Chief Executive Officer | Chief Executive Officer | 2013 – 2014 |
TA Chief Executive Officer | Chief Executive Officer | 2012 – 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2026 | |
| Chairman | 2016 | |
| Former (5) | ||
| Board of Directors | 2013 – 2014 | |
| Chairman | 2015 – 2016 | |
| Chairman | 2014 – 2015 | |
| Board of Directors | 2016 – 2026 | |
| Board of Directors | 2009 – 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2024 | |
| Company | 50–66.65% | 50–66.65% | 2016 | |
| Individual | 25–33.32% | 25–33.32% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Chr. Olesen Holding II A/SCHR. OLESEN HOLDING A/SCHR. OLESEN A/S
CHR. OLESEN PHARMACEUTICALS A/S (this company)Board members of CHR. OLESEN PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Christian Olesen | Management | 0 companies |
| Svend Aage Johansen | Chief Executive Officer | 0 companies |
| Phillip Christian Dam Quitzau Olesen | Management | 0 companies |
| Terje Aarbogh | Chief Executive Officer | 0 companies |
| Christian Dam Olesen | Chief Executive Officer | 0 companies |
| Allan Ardensø | Board of Directors | 0 companies |
| Fabian von Volkmann | Board of Directors | 0 companies |
| Tobias Facklam | Chairman | 0 companies |
| Jens H Thorsen | Chairman | 0 companies |
| Hans-Hermann Will | Chairman | 0 companies |
| Hans Schröder-von Volkmann | Board of Directors | 0 companies |
| Jens Havskov Thorsen | Board of Directors | 0 companies |